Through collaborative hit-to-lead projects, identify new leads with activity in animal models of disease and the potential for further optimization
current phase of drug development
updated 29 Feb 2020
Hit-to-lead is a dynamic phase in the drug discovery cascade in which small molecule hits from high throughput screens are evaluated and undergo optimization to identify promising lead compounds.
Get our latest news, personal stories, research articles, and job opportunities.